Open AccessIrbesartan is equally effective in reducing microalbuminuria in hypertensive non diabetic patients as in type 2 diabetic subjects: Effect of 1-year treatment in clinical settings
Author(s) -
Fernando de Álvaro,
J. Honorato,
Carlos Calvo,
C FILOZOF,
Olaia Velasco,
María Gracia SánchezAlonso,
I PARRONDO
Publication year - 2005
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1016/j.amjhyper.2005.03.146
Subject(s) - irbesartan , medicine , microalbuminuria , albuminuria , type 2 diabetes , diabetes mellitus , endocrinology , blood pressure , empagliflozin , hydrochlorothiazide , urology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom